Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Parvest Equity World Health Care

+ Add to Watchlist

GEQ4309:LX

747.36 EUR 4.04 0.54%

As of 00:59:30 ET on 03/03/2015.

Snapshot for Parvest Equity World Health Care (GEQ4309)

Year To Date: +18.58% 3-Month: +18.97% 3-Year: +32.57% 52-Week Range: 468.04 - 751.87
1-Month: +6.98% 1-Year: +46.44% 5-Year: +21.71% Beta vs MXWO0HC: 1.09

Mutual Fund Chart for GEQ4309

No chart data available.
  • GEQ4309:LX 747.36
  • 1M
  • 1Y
Interactive GEQ4309 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for GEQ4309

Parvest Equity World Health Care is a SICAV incorporated in Luxembourg. The Fund invests at least two-thirds of its assets in shares representing the capital of companies throughout the world involved in the health care and related sectors, and any other type of securities relating to such companies or sectors.

Inception Date: 03-17-1997 Telephone: 32-2-274-93-11
Managers: CHRISTIAN FAY
Web Site: www.bnpparibas-ip.com

Fundamentals for GEQ4309

NAV (on 2015-03-03) 747.36
Assets (M) (on 2015-03-03) 453.64
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for GEQ4309

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-04-16) 9.99
Dividend Yield (ttm) 1.34

Fees & Expenses for GEQ4309

Front Load -
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.84

Top Fund Holdings for GEQ4309

Filing Date: 08/31/2014
Name Position Value % of Total
Roche Holding AG 79,268 17,590,288 5.708%
Merck & Co Inc 378,056 17,252,464 5.599%
Gilead Sciences Inc 200,337 16,362,173 5.310%
Johnson & Johnson 173,092 13,631,061 4.424%
AbbVie Inc 294,535 12,360,989 4.011%
Pfizer Inc 499,191 11,138,190 3.615%
Celgene Corp 152,741 11,018,410 3.576%
Bayer AG 93,970 9,589,639 3.112%
AstraZeneca PLC 153,953 8,864,696 2.877%
Actavis plc 50,421 8,688,550 2.820%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil